From: Prognostic value of the NLR combined with CIP2A in the serum of patients with colorectal cancer
 | Univariable Cox regression | Multivariate Cox regression | ||||
---|---|---|---|---|---|---|
 | HR | CL (95%) | P | HR | CL (95%) | P |
Gender | Â | Â | 0.068 | Â | Â | NS |
Female | 1 | Â | Â | Â | Â | Â |
Male | 0.411 | 0.158–1.070 |  |  |  |  |
Age | Â | Â | 0.005 | Â | Â | 0.031 |
 < 65 | 1 |  |  | 1 |  |  |
 ≥ 65 | 3.686 | 1.468–9.251 |  | 3.089 | 1.111–8.585 |  |
Location | Â | Â | 0.616 | Â | Â | NS |
Colon | 1 | Â | Â | Â | Â | Â |
Rectum | 1.296 | 0.470–3.573 |  |  |  |  |
T stage | Â | Â | 0.012 | Â | Â | 0.343 |
T1–T2 | 1 |  |  | 1 |  |  |
T3–T4 | 1.703 | 1.122–2.585 |  | 1.731 | 0.556–5.390 |  |
N stage | Â | Â | 0.013 | Â | Â | 0.009 |
N0 | 1 | Â | Â | 1 | Â | Â |
N1–N2 | 3.274 | 1.282–8.359 |  | 4.401 | 1.456–13.304 |  |
M stage | Â | Â | 0.001 | Â | Â | 0.010 |
M0 | 1 | Â | Â | 1 | Â | Â |
M1 | 6.016 | 2.398–15.094 |  | 4.575 | 1.441–14.522 |  |
Intestinal obstruction | Â | Â | 0.005 | Â | Â | 0.123 |
No | 1 | Â | Â | 1 | Â | Â |
Yes | 3.686 | 1.468–9.251 |  | 2.668 | 0.766–9.294 |  |
CEA | Â | Â | 0.125 | Â | Â | NS |
 < 5 | 1 |  |  |  |  |  |
 ≥ 5 | 2.211 | 0.802–6.095 |  |  |  |  |
CA19-9 | Â | Â | 0.616 | Â | Â | NS |
 < 37 | 1 |  |  |  |  |  |
 ≥ 37 | 1.706 | 0.569–5.111 |  |  |  |  |
CIP2A | Â | Â | 0.192 | Â | Â | NS |
Low | 1 | Â | Â | Â | Â | Â |
High | 1.816 | 0.740–4.456 |  |  |  |  |
NLR | Â | Â | 0.012 | Â | Â | 0.519 |
 < 2.03 | 1 |  |  | 1 |  |  |
 ≥ 2.03 | 3.030 | 1.206–7.612 |  | 1.414 | 0.493–4.051 |  |
COCN | Â | Â | 0.020 | Â | Â | 0.232 |
0 | 1 | Â | Â | 1 | Â | Â |
1 + 2 | 4.829 | 1.278–18.251 |  | 2.714 | 0.528–13.946 |  |